It was a randomized controlled trial, single-blind study. Those with stage II or above MRSA-colonized wounds and who had given their informed consent formed the sample. The determined sample size was based on the effect size of our previous pilot study, which was 0.46. Five outcome measurements were taken for the MRSA bacterial count and wound healing condition at baseline and at 1-week intervals during the 4-week dressing intervention period.